Literature DB >> 10736426

Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.

M B Parent1, M K Habib, G B Baker.   

Abstract

Phenelzine (PLZ) is a non-selective monoamine oxidase (MAO) inhibitor commonly used to treat depression and panic disorder. Acute administration of PLZ produces several neurochemical changes, including an increase in brain levels of the catecholamines norepinephrine (NE) and dopamine (DA), of 5-hydroxytryptamine (5-HT), and of the amino acids alanine and gamma-aminobutyric acid (GABA). The goal of the present series of experiments was to characterize the time course of these PLZ-induced changes. Male Sprague-Dawley rats were sacrificed 6, 24, 48, 96, 168, or 336 hr after acute PLZ administration (15 or 30 mg/kg, i.p., based on free base weight). Whole brain levels of monoamines and amino acids were determined using HPLC, and MAO A and B activities were determined using a radiochemical procedure. The results indicated that PLZ changed amino acid levels 6 and 24 hr after injection, but not 48 hr later. In contrast, the effects of PLZ on MAO activity and monoamines were longer-lasting. For example, PLZ-induced increases in dopamine and 5-HT were observed 1 week after injection, and PLZ-induced inhibition of MAO activity persisted for 2 weeks. Thus, in addition to demonstrating that the effects of PLZ on MAO activity and monoamines were long-lasting, these results indicate that the effects of PLZ on MAO activity and on brain levels of monoamines and amino acids are temporally dissociated. These findings regarding the long-term effects of PLZ on neurochemistry will have considerable critical implications for the design and interpretation of behavioral studies of the acute effects of PLZ.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736426     DOI: 10.1016/s0006-2952(00)00244-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  Neurochemical and metabolic aspects of antidepressants: an overview.

Authors:  G B Baker; R T Coutts; A J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.

Authors:  V A Tanay; M B Parent; J T Wong; T Paslawski; I L Martin; G B Baker
Journal:  Cell Mol Neurobiol       Date:  2001-08       Impact factor: 5.046

3.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

4.  Down-regulated GABAergic expression in the olfactory bulb layers of the mouse deficient in monoamine oxidase B and administered with amphetamine.

Authors:  Hsiang-Shu Yin; Kevin Chen; Jean C Shih; Tai-Wei Tien
Journal:  Cell Mol Neurobiol       Date:  2009-11-10       Impact factor: 5.046

5.  The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.

Authors:  Christian Carpéné; Sandra Grès; Simon Rascalou
Journal:  J Neural Transm (Vienna)       Date:  2012-12-16       Impact factor: 3.575

6.  Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia.

Authors:  Jehoon Yang; Jun Shen
Journal:  J Neural Transm (Vienna)       Date:  2009-01-30       Impact factor: 3.575

7.  Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Authors:  Michael B Gatch; Cynthia M Taylor; Elva Flores; Meghan Selvig; Michael J Forster
Journal:  Behav Pharmacol       Date:  2006-03       Impact factor: 2.293

8.  Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.

Authors:  Thomas Del'guidice; Morgane Lemasson; Jean-Martin Beaulieu
Journal:  Front Neuroanat       Date:  2011-09-06       Impact factor: 3.856

9.  Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.

Authors:  Paul W Andrews; Susan G Kornstein; Lisa J Halberstadt; Charles O Gardner; Michael C Neale
Journal:  Front Psychol       Date:  2011-07-07

Review 10.  Neurobiology of memory and anxiety: from genes to behavior.

Authors:  Allan V Kalueff
Journal:  Neural Plast       Date:  2007-01-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.